A previously described defect of in vitro monocyte maturation in patients with squamous-cell carcinoma of the lung (SCC) has been investigated further. The maturation of patients' monocytes in pooled normal human serum was significantly better than in autologous serum. Conversely, the maturation of normal control monocytes was significantly depressed in patients' serum. The defect has been shown to be due to the presence of an inhibitory factor, rather than the lack of a necessary component in the patients' serum.
ABNORMAL FUNCTIONING of cells of the mononuclear phagocytic system (MPS) is commonly found in patients with cancer, particularly disseminated cancer. In a previous publication (Dent & Cole, 1981) we described a deficiency in the ability of monocytes from patients with squamouscell carcinoma of the lung (SCC) to mature into macrophages in vitro. Similar defects in monocyte maturation have previously been reported in patients with malignant melanoma (Currie & Hedley, 1977) and breast carcinoma (Taylor & Currie, 1979) . In all 3 studies the abnormality has been more marked in those with extensive disease.
There is considerable evidence that soluble serum factors are important in the genesis of disordered lymphocyte function in tumour-bearers, and more recently it has been suggested that similar mechanisms may be the basis of abnormal MPS function. Monocyte chemotaxis is depressed in the presence of soluble tumour factors (Maderazo et al., 1978) and the formation of macrophage-precursor colonies is poor in the presence of serum from tumour-bearers (Liu et al., 1979) . Also, in vitro phagocytosis of a test emulsion by monocytes is poor in the presence of serum from patients with a variety of solid tumours (Pisano et al., 1972) .
We have investigated the importance of serum factors in the poor monocyte maturation observed previously in patients with SCC. We have also examined the influence of soluble extracts of tumour and aggregated y-globulins on this assay. * Present address: Papworth Hospital, Papworth, Cambridgeshire.
PATIENTS, MATERIALS AND METHODS
Patients.-The study group comprised patients with definite SCC admitted to Brompton or London Chest Hospitals between June 1978 and November 1979 . They were divided into those with limited disease (confined to one lung with or without hilarnode involvement) and those with more extensive disease (involving the mediastinum, contralateral lung or supraclavicular nodes, with or without distant metastases). Twenty patients with limited and 20 with extensive disease were studied. Control patients comprised 60 with no chest disease, 33 with chronic obstructive airways disease (COAD) and 10 with terminal non-malignant disease, as previously described (Dent & Cole, 1981) .
Pooled normal human serum (NHS).-This was prepared from the pooled sera of 20 normal volunteers. The serum was separated in sterile plastic universals at 370C, and stored in lml aliquots at -70°C until required.
Monocyte maturation.-The assay was performed as described previously (Dent & Cole, 1981) . Briefly, defibrinated peripheral blood was layered on a mixture of Ficoll and Triosil (sp. gr. 1 077) and the mononuclear cells collected from the interface following centrifugation at 500 g for 35 min at room temperature. The cells were washed x 5 and adjusted to a concentration of 4 x 106/ml in RPMI 1640 (Flow Laboratories, Irvine) supplemented with L-glutamine (2 mM), penicillin (100 u/ml), streptomycin (100 ,ug/ml) and HEPES buffer (Gibco Europe, Glasgow) to a final concentration of 0-02 M. Fifty pul of cell suspension and 50 jud of serum were added to the wells of microtitre plates (Nunclon Delta, Denmark) and incubated at 370C in a humidified atmosphere of 5% C02 in air. Cytospin preparations (Shandon Southern) were made of the same cell suspensions and stained for non-specific esterase (NSE) (Yam et al., 1971) .
From these preparations the percentage of monocytes was estimated, a total of 300 cells being counted in each case.
After 7 days, each well was washed with medium to remove any non-adherent cells, and the remaining cells were counted as described previously (Dent & Cole, 1981) . Monocyte maturation was then calculated as the number of mature macrophages per well at Day 7, as a percentage of the number of monocytes placed in each well at Day 1. The mean of 5 wells was taken in each case.
Monocyte adherence.-Two 1d of 2 x 106/ml mononuclear cells in 50% serum were placed in each of 10 wells on microtitre plates and incubated for 2 h at 370C in a humidified atmosphere of 5% C02 in air. Each well was washed x 3 with medium and the number of cells adhering to the bottom of each well counted, and expressed as a percentage of NSE+ cells originally placed in each well. The 2h adherent populations were shown to consist of monocytes, with negligible ( < 1%) granulocyte contamination, by staining for NSE and chloracetate esterase (Yam et al., 1971) .
Immune complexes.-Polyethylene glycol precipitation was based on the method described by Creighton et al. (1973) and later by Chia et al. (1979) . Four hundred ,ul of serum was mixed with 120 ul of DL-dithiothreitol (Sigma; 5 ,ug/ml) and 1360 1l of PBS EDTA (0-01 M) and incubated for 15 min at 37°C.
One hundred and twenty tkl of H202 (0.2%) was added to each tube and mixed. Two ml of 7% polyethylene glycol (PEG) was added to each tube to give a final concentration of 3-5% PEG After incubation for 18 h at 40C, the precipitated material was separated by centrifugation at 9000 g for 20 min and redissolved in 100 ,u of borate buffer. The levels of immunoglobulin £G, A and M and of C3 and C4 were determined by single radial immunodiffusion (Mancini et al., 1965) . Results were expressed as a percentage of the total in untreated serum (derived from serum levels).
The conglutinin-binding assay was based on that described by Casali et al. (1977) with some adaptations. Bovine conglutinin was prepared (Lachmann & Hobart, 1978) and further purified by chromatography on DEAE cellulose. Two hundred and fifty ,ul of a 5,4g/ml conglutinin preparation was added to each well of a microelisa plate. The plate was covered with parafilm and foil and stored at 40C for at least 48 h. After washing x 3 in VBS-Tween 20 (0-025%) (Difco Laboratories Ltd, Detroit, Michigan) 250 pl of serum, diluted 1:100 or standard, was added to each well and the plates incubated for 3 h at 21 0C. After 3 further washes, 250 ,ul of conjugate (anti-IgG-alkaline phosphatase 1: 4000, Miles Yeda Ltd, Kiryot Weizmann, Rehovat, Israel) was added to each well and the plate incubated for 3 h at 210C. A further wash with VBS-Tween was followed by adding 200 ,ul of substrate p-nitro-phenyl phosphate (Signma) in carbonate buffer. At 30 rnin, 3N NaOH wvas added to each wN-ell to stop the reaction. UV absorption at 409 nm was recorded, and complex levels Nere calculated from a calibration curve constructed using preparations of alkaline-aggregated y-globulin in fresh NHS.
For both PEG precipitation and conglutinin binding, immune complexes wTere considered present if the levels measured exceeded the mean level established in 60 normal volunteers by > 2 s.d. Pregnancy-associated oX2-glycoprotein, (PA G). PAG levels were kindly measured by Drs I. Hunter and W. H. Stimson of Strathelyde University using a method described previously (Stimson, 1978) .
Preparation of aggregated y-globulin (AGG)
and its influence on monocyte maturation.-A 20mg/ml solution of y-globulin Cohn fraction 11 (Sigma Chemical Company, St Louis, Mass.) was mixed with an equal volume of 0-2M NaOH and allowed to stand for 10 min. Dialysis against PBS at room temperature for 2 h was followed by a similar dialysis overnight. The AGG was stored at 4°C until required. Concentration wvas determined by UV absorbance at 280 nm. AGG or unaggregated y-globulin was added to the wells of microtitre plates with the cell suspension to give a final concentration of 0-400 Mug/ml, and monocyte maturation wvas measured as described above. In a further study, the inonocytes were exposed to y-globulin for 30 min, Awashed 2 x in medium and distributed to wells of microtitre plates for measurement of monocyte maturation in 50%o serum.
Preparation of tissue extracts and their influence on monocyte maturation.-Tumour and surrounding lung tissues removed at operation wvere taken fresh to the laboratory and 30g pieces finely minced with scissors and homogenized in RPMI 1640 containing 1000 foetal calf serum (FCS) using a glass homogenizer. The preparations were spun at 8000 g for 15 min and the supernatants stored in 2ml aliquots at -70°C until required. Ten yul of tumour or lung extract was added to each well of microtitre plates, in addition to 50 ju of 2 x 106/ml mononuclear cells and 50 1ul of serum, and monocyte maturation performed. Control wvells containied an additional 10 yul of medium or 1000 FCS. In parallel experiments, mononuclear cells were exposed to the extracts or control medium at a final concenitration of 10% in siliconized glassware for 30 min, wAashed 2 x in medium and their concentration readjusted to 2 x 106 in RPMI 1640 and 50%/ serum before (listribution to microtitre plates for the measurement of maturation.
RESULTS
The effect of serum on monocyte maturation Maturation of monocytes from the 40 patients with SCC was performed in parallel in autologous serum and NHS. The results shown in Fig. 1 demonstrate that monocyte maturation was significantly better in NHS than in autologous serum from patients with both limited (P < 0.005) and extensive (P < 0 005) with either limited (mean 31 2 %) or extensive (mean 24.6%) SCC was significantly lower than the maturation of the same cells cultured in NHS (P<0 001) (Fig. 2) .
In 4 patients with SCC, a detailed analysis of the serum effect was undertaken (Table I) (Fig. 3 ). There was some inhibirom tion of maturation at higher concentracc.
tions of unaggregated y-globulin, but this was minimal comoared with that due to similar levels of AGG. A comparison of adherence and maturation at a concentration of 200 jg/ml y-globulin (Table II) revealed no difference in adherence at 2 h, but markedly reduced numbers of mature macrophages at 7 days, in the presence of AGG (P < 0-001). Exposing the monocytes to AGG for 30 min before washing them 2 x and culturing in normal autologous serum producd a percentage maturation marginally but significantly less than controls.
Immune complexes and monocyte maturation
Eight of the 20 patients with limited SCC (40%) and 13 of the 20 with extensive SCC (65%) had immune complexes present, as assessed by PEG precipitation or conglutinin binding (Table III) IgG, 0-9+0-6%; IgA, 1-2+1-0%; IgM, 5-6+7-4%; C3, 1.2+0-8%; C4, 1-0+1-2%; conglutinin binding, 9-9 + 9-1 jug/ml. no significant difference in mean monocyte maturation between those patients with and without immune complexes. The level of precipitated IgG, IgA, IgM, C3 or C4 could not be correlated with the percentage monocyte maturation. There was, however, a weak negative correlation between the level of conglutinin-binding complexes and in vitro monocyte maturation (Fig. 4 ).
Pregnancy-associated o2-glycoprotein (PAG) and monocyte maturation The levels of PAG in 5 female patients with SCC (mean 40 ,ug/ml) was similar to 601 . that in 6 female controls (mean 52 ,ug/ml). Although the mean PAG levels in male patients with limited SCC (31.5 jig/ml) were higher than in the 18 normal male controls (24-0 ,ug/ml) and 16 patients with COAD (18-6 ,g/ml), these differences were not statistically significant. Six of the 20 patients with limited SCC and 4 of the 20 patients with extensive SCC had PAG levels above the normal range for the laboratory in which the levels were measured. There was no difference in mean monocyte maturation between those patients with normal and those with raised PAG levels, and PAG levels did not correlate with levels of monocyte maturation.
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Effects of tumour and lung extracts on monocyte maturation
The soluble extracts of 4 resected SCC were tested in parallel with the extract from an equivalent weight of adjacent uninvolved lung, and control medium. Three normal monocyte preparations were cultured as described under Methods, to determine monocyte maturation, but adding 10 lzl of tumour extract, lung extract or RPMI 1640 with 10% FCS to each well. The tumour extract depressed maturation in all 4 cases (Table IV) from 35 to 84.4% of control values (P < 0.001). Two of the 4 extracts of adjacent lung also caused some depression (P < 0.05). Adherence at 2 h was slightly but not significantly lower than control values whenever tumour or uninvolved lung supernatant was present. Exposure to tumour extracts for 30 min, followed by 2 washes in fresh medium, produced significant but much less depression of maturation of monocytes subsequently cultured in autologous serum.
DISCUSSION
In this communication we attempt to 92-5+15-4p<O-00l 96-8±1-2 p< -Tumour 89-5+d2-6 56-8+18-7} 83-9+J5-P7 t In the presence of extracts expressed as % of results in autologous serum + FCS. . In 50% autologous serum after incubation with extracts for 30 min, followed by 2 washes in fresh medium; expressed as % of result in autologous serum + FCS.
Each result represents the mean of 3 sets of normal monocytes. Significance of difference from control values (assessed by analysis of variance): * P < 0 05. ** P < 0-001. A .
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. analyse the factors responsible for the abnormality of in vitro monocyte maturation described in a previous paper (Dent & Cole, 1981) . The defect has been shown to be due, in part at least, to a serum factor, since maturation of SCC patients' monocytes was consistently and statistically better in NHS than in autologous serum, and maturation of normal monocytes was depressed in the presence of patients' serum. The maturation of monocytes from SCC patients could be improved by washing x 4 with medium, though the result was still well short of that obtained with monocytes from normal controls. This suggests the presence of inhibitory material on the cells which is removed by thorough washing, though an alternative explanation could be the selective loss during successive washes of monocytes with poor maturation potential. The evidence from studying 4 sets of monocytes in detail suggests inhibitory factor(s) in SCC patients, rather than a deficiency of something necessary for normal maturation, since the addition of just 10%1 of autologous serum to 500% NHS reduces maturation of patients' monocytes below that in 5000 or 60°N HS alone. The residual deficiency in maturation of monocytes from SCC patients after repeated washing may be explained by failure to remove completely an adherent inhibitory factor or factors, or alternatively may, as suggested by Nyholm & Currie (1978) , represent a state of activation of monocytes in cancer patients.
Most functions of cells of the MPS are enhanced in tumour-bearers, at least during early growth, but monocyte chemotaxis (Boetcher & Leonard, 1974; Hausman et al., 1975) and maturation (Currie & Hedley, 1977; Taylor & Currie, 1979) have been consistently reported as depressed. Snyderman & Pike (1976) described a low-mol.-wt factor, released by murine neoplasms, that inhibited macrophage chemotaxis both in vivo and in vitro, and they proposed, as a possible mechanism, an effect on the activation or matura-tion of moinonuclear phagocytes into chemotactically responsive cells. Soluble factors interfering with monocyte chemotaxis have also been described in patients with a variety of tumours (Maderazo et al., 1978) and monocyte spreading may be inhibited by sera from tumour-bearing patients (Laurentaci & Favoino, 1977) .
Most work on soluble factors that interfere with cellular immunity has concerned abnormal lymphocyte function, and a variety of tumour-and host-derived materials have been implicated, involving specific and nonspecific mechanisms. Specific factors, including tumour antigens, tumour antibodies and immune complexes and the evidence for their importance to lymphocyte function in tumour-bearers, has been extensively reviewed (Baldwin & Robins, 1975) . Recently it has been suggested that immune complexes may influence MPS function in tumour-bearers (Michl et al., 1979; Rao et al., 1979) and in patients with systemic lupus erythematosus a defect of in vitro monocyte adherence at 4 days (an assay similar to that described here) was thought to be due to the presence of immune complexes (Svensson, 1975) . Aggregated y-globulin has been shown to inhibit neutrophil chemotaxis (Kemp et al., 1979) , as have IgA soluble immune complexes (Ito et al., 1979) and the lysis of red blood cells by monocytes is inhibited by AGG (Nyholm & Currie, 1978) in a dose-related fashion similar to the inhibition of monocyte maturation by AGG in our experiments. The evidence that complexes may interfere with maturation is interesting in view of the prevalence of immune complexes in SCC, described here and confirmed bv others in patients with lung carcinomas (Gropp et al., 1980) . However, we were unable to demonstrate a consistent correlation between the presence of immune complexes and in vitro monocyte maturation. The weak relation between conglutinin-binding complexes and poor monocyte maturation may reflect a chance occurrence, since both immune complexes (Gropp et al., 1980; Theofilopoulos et al., 1977) and depressed monocyte maturation (Dent & Cole, 1981) are more common with increasing extent of the disease. Alternatively, conglutinin binding may be a better measure of the type of complex that binds to monocytes (or is consumed by them) altering their function, than is PEG precipitation. Israel & Edelstein (1978) have emphasized the importance of nonspecific inhibitors of cellular immune function in tumour-bearers, either tumouror hostderived. One such material, which has been investigated in some detail, is PAG (Stimson, 1975) ; it is found in increased levels in many patients with tumours, including lung carcinomas (Bauer et al., 1977) and suppresses lymphocyte function (Stimson, 1976) . The levels recorded in our 40 SCC patients demonstrated a wide scatter, as found by previous workers. However, there was no correlation between PAG level and monocyte maturation, even when the sexes were considered separately. Thus we have no evidence that PAG has any suppressive action on this aspect of monocyte function.
There is some evidence that the position locally (within and at the edge of tumours) may be different from that found systemically, owing perhaps to the high concentration of factors produced by the tumour. The expression of Fe receptors on monocytes, for instance, though enhanced by serum from patients with tumours, is inhibited by tumour supernatants (Rhodes et al., 1979) . It has been shown that tumour supernatants can inhibit the movement of macrophages both in vivo and in vitro (Snyderman & Pike, 1976 ) and we were interested to find that lung extracts had minimal effects on monocyte 2 h adherence or maturation at 7 days, but that tumour extracts prepared similarly caused a substantial inhibition of maturation. It is likely that whatever the tumour produces is firmly bound to the monocytes, since a significant though less marked inhibition of maturation at 7 days occurred after exposure of the monocytes for only 30 min followed by 2 washes.
The data available on serum inhibitory materials in cancer patients suggest that no one substance, specific or nonspecific, is responsible for the observed defects of lymphocyte or MPS function, and that systemic function may be very different from the function of similar cells in the vicinity of a tumour. The complexity of the clinical situation may confound attempts to identify direct correlations between suppressive soluble factors and cellular functions. Therefore it cannot be inferred that the presence of immune complexes or increased levels of PAG in our patients has no importance to monocyte maturation in vivo.
There have been attempts to isolate soluble materials responsible for inhibition of macrophage functions. The materials described have diverse properties and sizes (Snyderman & Pike, 1976; Brozna & Ward, 1975; Fauve et al., 1974; Rhodes et al., 1979; North et al., 1976) only serving to support the contention that there are many hostand tumour-derived materials that can influence cellular immune function.
